UNIVERSAL IBOGAINE ANNOUNCES CHIEF CLINICS OFFICER DR IAN RABB
Universal Ibogaine and PSQ are pleased to announce the completion of the Qualifying Transaction, closing the $6 million subscription receipt financing.
Universal Ibogaine and PSQ are pleased to announce the completion of the Qualifying Transaction, closing the $6 million subscription receipt financing.
Universal Ibogaine and PSQ are pleased to announce the completion of the Qualifying Transaction, closing the $6 million subscription receipt financing.
Universal Ibogaine and PSQ are pleased to announce the completion of the Qualifying Transaction, closing the $6 million subscription receipt financing.
Universal Ibogaine and PSQ are pleased to announce the completion of the Qualifying Transaction, closing the $6 million subscription receipt financing.
Universal Ibogaine and PSQ are pleased to announce the completion of the Qualifying Transaction, closing the $6 million subscription receipt financing.
Universal Ibogaine and PSQ are pleased to announce the completion of the Qualifying Transaction, closing the $6 million subscription receipt financing.
Universal Ibogaine and PSQ are pleased to announce the completion of the Qualifying Transaction, closing the $6 million subscription receipt financing.
Universal Ibogaine and PSQ are pleased to announce the completion of the Qualifying Transaction, closing the $6 million subscription receipt financing.
Universal Ibogaine and PSQ are pleased to announce that PSQ has SEDAR filed...
Calgary, Alberta - P Squared Renewables Inc. (TSXV: PSQ.P) ("PSQ" or the "Company") a capital pool company, and Universal Ibogaine Inc. ("UI") are pleased to announce that PSQ has received conditional approval from the TSX Venture Exchange ("TSXV") for its previously announced Qualifying Transaction (the "Transaction", as defined under TSX.V Policy 2.4) with UI. Pursuant to the Transaction, PSQ will [...]